You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

List of Excipients in API OLUTASIDENIB

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing OLUTASIDENIB

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Rigel Pharmaceuticals Inc	REZLIDHIA	olutasidenib	71332-005	CELLULOSE, MICROCRYSTALLINE	2029-12-01
Rigel Pharmaceuticals Inc	REZLIDHIA	olutasidenib	71332-005	CROSCARMELLOSE SODIUM	2029-12-01
Rigel Pharmaceuticals Inc	REZLIDHIA	olutasidenib	71332-005	FERROSOFERRIC OXIDE	2029-12-01
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for OLUTASIDENIB

Excipient focus: CELLULOSE, MICROCRYSTALLINE

OLUTASIDENIB drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

OLUTASIDENIB drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

OLUTASIDENIB drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

OLUTASIDENIB drug variants containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

OLUTASIDENIB drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

OLUTASIDENIB drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

OLUTASIDENIB drug variants containing SHELLAC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing SHELLAC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

OLUTASIDENIB drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rigel Pharmaceuticals Inc	olutasidenib	71332-005
>Company	>Ingredient	>NDC

OLUTASIDENIB drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.